EGFR and small cell lung carcinoma: Although liquid biopsy is a tool for diagnosing the presence of T790M in patients with EGFR-TKI-resistant NSCLC, tissue biopsy should be considered for patients with low T790M/activating mutation ratios in order to rule out the presence of SCLC transformation and/or other concomitant resistance mechanisms [115].